| pubmed-article:9626218 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9626218 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:9626218 | lifeskim:mentions | umls-concept:C0008109 | lld:lifeskim |
| pubmed-article:9626218 | lifeskim:mentions | umls-concept:C0027819 | lld:lifeskim |
| pubmed-article:9626218 | lifeskim:mentions | umls-concept:C0029463 | lld:lifeskim |
| pubmed-article:9626218 | lifeskim:mentions | umls-concept:C0281581 | lld:lifeskim |
| pubmed-article:9626218 | lifeskim:mentions | umls-concept:C0920321 | lld:lifeskim |
| pubmed-article:9626218 | lifeskim:mentions | umls-concept:C0205269 | lld:lifeskim |
| pubmed-article:9626218 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:9626218 | pubmed:dateCreated | 1998-7-1 | lld:pubmed |
| pubmed-article:9626218 | pubmed:abstractText | To evaluate the toxicity, immunogenicity, and pharmacokinetics of a human-mouse chimeric monoclonal antibody (mAb) ch 14.18 directed against disialoganglioside (GD2) and to obtain preliminary information on its clinical efficacy, we conducted a phase I trial in 10 patients with refractory neuroblastoma and one patient with osteosarcoma. | lld:pubmed |
| pubmed-article:9626218 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9626218 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9626218 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9626218 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9626218 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9626218 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9626218 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9626218 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9626218 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9626218 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9626218 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9626218 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9626218 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9626218 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9626218 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:9626218 | pubmed:issn | 0732-183X | lld:pubmed |
| pubmed-article:9626218 | pubmed:author | pubmed-author:HuangC SCS | lld:pubmed |
| pubmed-article:9626218 | pubmed:author | pubmed-author:ReisfeldR ARA | lld:pubmed |
| pubmed-article:9626218 | pubmed:author | pubmed-author:JOSTKK | lld:pubmed |
| pubmed-article:9626218 | pubmed:author | pubmed-author:YuA LAL | lld:pubmed |
| pubmed-article:9626218 | pubmed:author | pubmed-author:GilliesS DSD | lld:pubmed |
| pubmed-article:9626218 | pubmed:author | pubmed-author:Uttenreuther-... | lld:pubmed |
| pubmed-article:9626218 | pubmed:author | pubmed-author:TsuiC CCC | lld:pubmed |
| pubmed-article:9626218 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9626218 | pubmed:volume | 16 | lld:pubmed |
| pubmed-article:9626218 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9626218 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9626218 | pubmed:pagination | 2169-80 | lld:pubmed |
| pubmed-article:9626218 | pubmed:dateRevised | 2011-7-29 | lld:pubmed |
| pubmed-article:9626218 | pubmed:meshHeading | pubmed-meshheading:9626218-... | lld:pubmed |
| pubmed-article:9626218 | pubmed:meshHeading | pubmed-meshheading:9626218-... | lld:pubmed |
| pubmed-article:9626218 | pubmed:meshHeading | pubmed-meshheading:9626218-... | lld:pubmed |
| pubmed-article:9626218 | pubmed:meshHeading | pubmed-meshheading:9626218-... | lld:pubmed |
| pubmed-article:9626218 | pubmed:meshHeading | pubmed-meshheading:9626218-... | lld:pubmed |
| pubmed-article:9626218 | pubmed:meshHeading | pubmed-meshheading:9626218-... | lld:pubmed |
| pubmed-article:9626218 | pubmed:meshHeading | pubmed-meshheading:9626218-... | lld:pubmed |
| pubmed-article:9626218 | pubmed:meshHeading | pubmed-meshheading:9626218-... | lld:pubmed |
| pubmed-article:9626218 | pubmed:meshHeading | pubmed-meshheading:9626218-... | lld:pubmed |
| pubmed-article:9626218 | pubmed:meshHeading | pubmed-meshheading:9626218-... | lld:pubmed |
| pubmed-article:9626218 | pubmed:meshHeading | pubmed-meshheading:9626218-... | lld:pubmed |
| pubmed-article:9626218 | pubmed:meshHeading | pubmed-meshheading:9626218-... | lld:pubmed |
| pubmed-article:9626218 | pubmed:meshHeading | pubmed-meshheading:9626218-... | lld:pubmed |
| pubmed-article:9626218 | pubmed:meshHeading | pubmed-meshheading:9626218-... | lld:pubmed |
| pubmed-article:9626218 | pubmed:meshHeading | pubmed-meshheading:9626218-... | lld:pubmed |
| pubmed-article:9626218 | pubmed:meshHeading | pubmed-meshheading:9626218-... | lld:pubmed |
| pubmed-article:9626218 | pubmed:meshHeading | pubmed-meshheading:9626218-... | lld:pubmed |
| pubmed-article:9626218 | pubmed:meshHeading | pubmed-meshheading:9626218-... | lld:pubmed |
| pubmed-article:9626218 | pubmed:meshHeading | pubmed-meshheading:9626218-... | lld:pubmed |
| pubmed-article:9626218 | pubmed:meshHeading | pubmed-meshheading:9626218-... | lld:pubmed |
| pubmed-article:9626218 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9626218 | pubmed:articleTitle | Phase I trial of a human-mouse chimeric anti-disialoganglioside monoclonal antibody ch14.18 in patients with refractory neuroblastoma and osteosarcoma. | lld:pubmed |
| pubmed-article:9626218 | pubmed:affiliation | Department of Pediatrics, University of California San Diego 92103-8447, USA. alyu@ucsd.edu | lld:pubmed |
| pubmed-article:9626218 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9626218 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:9626218 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:9626218 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:9626218 | pubmed:publicationType | Clinical Trial, Phase I | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9626218 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9626218 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9626218 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9626218 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9626218 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9626218 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9626218 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9626218 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9626218 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9626218 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9626218 | lld:pubmed |
